Abstract
Objective: To evaluate the effect of Shentekang Capsule (STKC) combined with peritoneal dialysis (PD) in treating chronic renal failure (CRF).Methods: With single-blind, parallel control and random method, 60 cases of CRF patients were equally divided into 2 groups: (1) STKC group treated with combined therapy of STKC and PD; (2) control group treated with PD alone. The course of treatment were 1~2 months for both groups. Clinical manifestations, blood urea nitrogen, serum creatinine, total protein and hemoglobin were observed before and after the treatment. Results: Blood urea nitrogen decreased in both groups after treatment as compared with that before treatment significantly (P < 0.05), but no obvious difference was found between blood urea nitrogen levels of the two groups (P > 0. 05). However, levels of serum total protein and hemoglobin of the STKC group after treatment were higher than those of the control group (P < 0.01). Clinical manifestation in STKC group also showed more improvement after treatment than that in the control group. Conclusion: STKC could improve nutritional state and quality of CRF patient’s life treated with PD.
Similar content being viewed by others
References
1991: 300.
1991; (7): 277.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ye, RG., Ren, GH., Li, HQ. et al. Clinical observation on 30 cases of chronic renal failure treated with Shentekang Capsule and peritoneal dialysisand peritoneal dialysis. CJIM 3, 10–11 (1997). https://doi.org/10.1007/BF02935426
Issue Date:
DOI: https://doi.org/10.1007/BF02935426